Cargando…
Systemic treatment with or without ablative therapies in oligometastatic breast cancer: A single institution analysis of patient outcomes
PURPOSE: Local ablative treatment (LAT) is increasingly combined with systemic therapy in oligometastatic breast cancer (OMBC), without a high-level evidence to support this strategy. We evaluated the addition of LAT to systemic treatment in terms of progression-free survival (PFS) and overall survi...
Autores principales: | Glemarec, Gauthier, Lacaze, Jean-Louis, Cabarrou, Bastien, Aziza, Richard, Jouve, Eva, Zerdoud, Slimane, De Maio, Eleonora, Massabeau, Carole, Loo, Maxime, Esteyrie, Vincent, Ung, Mony, Dalenc, Florence, Izar, Francoise, Chira, Ciprian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982270/ https://www.ncbi.nlm.nih.gov/pubmed/36709639 http://dx.doi.org/10.1016/j.breast.2022.12.035 |
Ejemplares similares
-
Diagnosis, biology and epidemiology of oligometastatic breast cancer
por: Lacaze, Jean-Louis, et al.
Publicado: (2021) -
Helical tomotherapy for post-mastectomy radiation therapy with or without breast implant: a single institution experience
por: Dejean, Romain, et al.
Publicado: (2022) -
Recurrent Extradural Myxopapillary Ependymoma With Oligometastatic Spread
por: Batich, Kristen A., et al.
Publicado: (2019) -
(18)F-Fluorine-18-l-dihydroxyphenylalanine ((18)F-DOPA) positive isolated peritoneal carcinomatosis from a MENII-related medullary thyroid carcinoma. About an atypical metastatic site and utility of (18)F-FDOPA
por: Aziz, Anne-Laure, et al.
Publicado: (2015) -
Oligometastatic Prostate Cancer
por: Stevens, Daniel J., et al.
Publicado: (2016)